TWINBEECH CAPITAL LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
TWINBEECH CAPITAL LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$4,010,701
+127.9%
101,717
+108.7%
0.08%
+65.2%
Q3 2022$1,760,000
+425.4%
48,750
+342.3%
0.05%
+206.7%
Q2 2022$335,000
-60.1%
11,023
-59.9%
0.02%
-59.5%
Q1 2022$840,000
+290.7%
27,468
+299.4%
0.04%
+208.3%
Q4 2021$215,0006,8780.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders